Pharmaceutical The Tokyo District Court today rendered judgment to deny the plaintiff’s claim in the lawsuit filed on February 17, 2021 regarding the generic drugs to an osteoporosis agent, active vitamin D3 derivative Edirol Capsule (eldecalcitol) based on the patent owned by Japanese pharma major Chugai Pharmaceuticals against Sawai Pharmaceutical, Nichi-Iko Pharmaceutical and Nissan Chemical. 24 February 2022